Literature DB >> 1059360

Nucleoside analogs in the treatment of neoplastic and nonneoplastic diseases.

M Slavik.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 1059360     DOI： 10.1111/j.1749-6632.1975.tb29234.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  2 in total

1.  ARC (NSC 188491) has identical activity to Sangivamycin (NSC 65346) including inhibition of both P-TEFb and PKC.

Authors:  Luke H Stockwin; Sherry X Yu; Howard Stotler; Melinda G Hollingshead; Dianne L Newton
Journal:  BMC Cancer       Date:  2009-02-20       Impact factor: 4.430

2.  Protein kinase C: an attractive target for cancer therapy.

Authors:  Barbara Marengo; Chiara De Ciucis; Roberta Ricciarelli; Maria A Pronzato; Umberto M Marinari; Cinzia Domenicotti
Journal:  Cancers (Basel)       Date:  2011-02-01       Impact factor: 6.639
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.